:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
fda update on semaglutide What's New in Obesity Treatment? FDA-Approved Oral Semaglutide: The First
Description
For some infertility phenotypes associated strongly with metabolic dysfunction, such as PCOS with obesity and insulin resistance, GLP-1 RAs could be contemplated prior to or concurrently with standard ovulation agents like clomiphene or letrozole
Scientific Session
The key difference is between pungent capsaicin from hot peppers versus aromatic herbs that enhance taste without irritating mucous membranes
One in 8 American adults now takes a GLP-1 drug of some kind
FDA approval requires Phase 3 completion, data analysis, peer review, and FDA evaluation
